Cost of respiratory syncytial virus hospitalisation in Brazilian infants: a micro-costing study from the perspective of a Brazilian tertiary public hospital, 2020–2023
RSV-related hospitalisations impose a significant economic burden on this Brazilian tertiary public hospital, mainly related to bed cost per day and intensive care needs in young infants. These findings highlight the need for cost-effective RSV management and prevention strategies in Brazil.
Authors
- Fernando Pereira (ORCID: https://orcid.org/0000-0002-3294-3084)
- Paulo Henrique Ribeiro Fernandes Almeida (ORCID: https://orcid.org/0000-0002-9369-0690)
- Armèle Dornelas de Andrade (ORCID: https://orcid.org/0000-0001-9430-4395)
- Daniela Vianna Pachito (ORCID: https://orcid.org/0000-0002-7052-7735)
- Ancelmo Honorato Ferraz de Sousa
- Lital Moro Bass
- R.F. Alexandre
- Sebastián Vernal (ORCID: https://orcid.org/0000-0001-8589-0089)
- Sónia Silva (ORCID: https://orcid.org/0000-0002-3655-5580)
- Alessandro Flora (ORCID: https://orcid.org/0000-0001-7788-7832)
- Leonardo Henrique Fiuza de Meireles
- Nancy Oliveira dos Santos
- Caroline Pimenta Nunes
- Carla Souza Behr Pitoli
- Edgard Joseph Kiriyama
- Luís Felipe Batista Hiar (ORCID: https://orcid.org/0000-0002-3651-7832)
Institutions
- Pfizer (United States) (US)
- Hospital Israelita Albert Einstein (BR)
- Hospital Municipal São José (BR)
Publication Details
- Journal
- BMC Public Health
- Published
- 2025-07-26
- DOI
- https://doi.org/10.1186/s12889-025-23636-w
- Primary Topic
- Respiratory viral infections research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Pfizer